NEOsphere Biotechnologies GmbH Company Profile, Contacts & Intelligence

NEOsphere Biotechnologies GmbH Overview

NEOsphere Biotechnologies integrates world-class mass spectrometry with expert data analysis to systematically build comprehensive pipelines of novel degrader targets. We support our partners' targeted protein degradation (TPD) drug discovery programs across all stages. Our deep proteomic screening platform, which is target- and E3 ligase-agnostic, enables unbiased, high-throughput screening of entire degrader libraries. With unparalleled proteome coverage, sensitivity, precision, and rapid turnaround, we unlock the previously undruggable target space. Our platform characterizes all degrader types, identifying molecules that engage new E3 ligases and emerging TPD mechanisms. We confirm potential degrader targets and modifications through global ubiquitinomics, achieving unprecedented coverage of > 50,000 ubiquitination sites. Our proprietary data analysis suite is designed for interactive and user-friendly exploration of large proteomics datasets, enabling informed decision-making, SAR optimization, target identification, and library expansion.

Headquarters

Planegg, Bayern, De

Website

www.neospherebiotechnologies.com

Industry

Biotechnology Research

Founded

2022

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

NEOsphere Biotechnologies GmbH Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

NEOsphere Biotechnologies GmbH People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

NEOsphere Biotechnologies GmbH Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to NEOsphere Biotechnologies GmbH

Explore companies in related markets and compare their industry and employee estimates.